NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 12th Aug 2025 NOVO-B STOCK Price closed @ 320.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 844.58 & Strong Sell for SHORT-TERM with Stoploss of 875.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 322.60 Change Price %
High 324.95 1 Day -2.10 -0.65
Low 316.30 1 Week 11.70 3.79
Close 320.50 1 Month -117.85 -26.88
Volume 5905899 1 Year -510.30 -61.42
52 Week High 1028.00 | 52 Week Low 289.50
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 320.50 -0.65%
CONFRZ 0.02 0.00%
VWS 116.65 4.71%
ORSTED 213.90 -1.47%
DANSKE 271.00 1.65%
GREENH 0.41 -6.82%
ASTRLS 1.15 8.49%
ISS 187.30 1.13%
ALMB 18.33 0.05%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
DAC 14.50 10.69%
DAC 14.50 10.69%
DAC 14.50 10.69%
SAME 1.45 10.69%
SAME 1.45 10.69%
ASTRLS 1.15 8.49%
STENO 0.73 5.80%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
AQP 7.72 -20.08%
BLVIS-A 0.40 -18.37%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE337.17
RESISTANCE331.82
RESISTANCE328.52
RESISTANCE325.21
SUPPORT315.79
SUPPORT312.48
SUPPORT309.18
SUPPORT303.83
 
NOVO-B Forecast August 2025
4th UP Forecast487.96
3rd UP Forecast434.25
2nd UP Forecast401.06
1st UP Forecast367.86
1st DOWN Forecast273.14
2nd DOWN Forecast239.94
3rd DOWN Forecast206.75
4th DOWN Forecast153.04
 
NOVO-B Weekly Forecast
4th UP Forecast463.87
3rd UP Forecast417.89
2nd UP Forecast389.47
1st UP Forecast361.05
1st DOWN Forecast279.95
2nd DOWN Forecast251.53
3rd DOWN Forecast223.11
4th DOWN Forecast177.13
 
NOVO-B Forecast2025
4th UP Forecast1757.27
3rd UP Forecast1296.49
2nd UP Forecast1011.67
1st UP Forecast726.85
1st DOWN Forecast-85.85
2nd DOWN Forecast-370.67
3rd DOWN Forecast-655.49
4th DOWN Forecast-1116.27
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service